STOCK TITAN

Major holder Timothy P. Lynch reports 9.9% stake in Evolus (EOLS)

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Timothy P. Lynch reports beneficial ownership of 6,425,726 shares of Evolus, Inc. common stock, representing 9.9% of the class. This includes 4,705,009 shares over which he has sole voting and dispositive power and 1,720,717 shares with shared voting and dispositive power.

The ownership percentage is based on 64,819,784 shares of Evolus common stock outstanding as of October 31, 2025, as reported by the company. Lynch states that the securities were not acquired and are not held for the purpose of changing or influencing control of Evolus.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: The percentages reported in this Schedule 13G are based on 64,819,784 shares of Common Stock outstanding as of October 31, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended September 30, 2025.


SCHEDULE 13G



Timothy P. Lynch
Signature:/s/ Timothy P. Lynch
Name/Title:Reporting person
Date:02/17/2026

FAQ

What ownership stake does Timothy P. Lynch report in Evolus (EOLS)?

Timothy P. Lynch reports beneficial ownership of 6,425,726 shares of Evolus common stock, representing 9.9% of the outstanding class. This disclosure indicates he is a significant shareholder but remains under the 10% threshold often associated with control considerations.

How are Timothy P. Lynch’s Evolus (EOLS) shares divided between sole and shared power?

Lynch reports 4,705,009 shares with sole voting and dispositive power and 1,720,717 shares with shared voting and dispositive power. This breakdown shows where he alone controls the shares versus where control is shared with other parties.

What share count did Evolus (EOLS) report outstanding for calculating the 9.9% stake?

The 9.9% ownership is calculated using 64,819,784 shares of Evolus common stock outstanding as of October 31, 2025. This outstanding share figure comes from Evolus’s Form 10-Q for the quarter ended September 30, 2025.

Is Timothy P. Lynch seeking to influence control of Evolus (EOLS)?

Lynch certifies that the Evolus securities were not acquired and are not held for the purpose of changing or influencing control of the company. He also states they are not held in connection with any transaction having that control-changing purpose or effect.

What type of reporting person is Timothy P. Lynch in this Evolus (EOLS) disclosure?

Lynch is identified as an individual U.S. citizen reporting beneficial ownership of Evolus common stock. He does not classify himself as a broker, bank, investment adviser, or other institutional filer category under the Schedule 13G reporting framework.

On what date did the Evolus (EOLS) ownership level trigger this Schedule 13G/A report?

The report is tied to an event date of December 31, 2025. That date reflects when the ownership information became reportable under beneficial ownership rules, prompting the updated Schedule 13G/A submission by Timothy P. Lynch.
Evolus

NASDAQ:EOLS

EOLS Rankings

EOLS Latest News

EOLS Latest SEC Filings

EOLS Stock Data

278.73M
53.54M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
NEWPORT BEACH